Low RAI2 expression is a marker of poor prognosis in breast cancer

被引：0
|
作者：
Sayaka Nishikawa
Yasuaki Uemoto
Tae-Sun Kim
Tomoka Hisada
Naoto Kondo
Yumi Wanifuchi-Endo
Takashi Fujita
Tomoko Asano
Yusuke Katagiri
Mitsuo Terada
Akiko Kato
Yu Dong
Hiroshi Sugiura
Katsuhiro Okuda
Hiroyuki Kato
Satoshi Osaga
Satoru Takahashi
Tatsuya Toyama
机构：
[1] Nagoya City University Graduate School of Medical Sciences,Department of Breast Surgery
[2] Nagoya City University Graduate School of Medical Sciences,Advanced Medicine
[3] Nagoya City University Graduate School of Medical Sciences,Department of Oncology, Immunology and Surgery
[4] Nagoya City University Graduate School of Medical Sciences,Department of Experimental Pathology and Tumor Biology
[5] Nagoya City University Hospital,Clinical Research Management Center
[6] Toyokawa City Hospital,Department of Breast and Endocrine Surgery
来源：
Breast Cancer Research and Treatment | 2021年 / 187卷
关键词：
Breast cancer; Retinoic acid-induced 2 (RAI2); Disseminated tumor cells (DTC);
D O I：
暂无
中图分类号：
学科分类号：
摘要：
引用
收藏
页码：81 / 93
页数：12
相关论文
共 50 条
  • [21] Vimentin expression is not associated with poor prognosis in breast cancer
    Seshadri, R
    Raymond, WA
    Leong, ASY
    Horsfall, DJ
    McCaul, K
    INTERNATIONAL JOURNAL OF CANCER, 1996, 67 (03) : 353 - 356
  • [22] Low expression of Mel-18 predicts poor prognosis in patients with breast cancer
    Guo, B. -H.
    Zhang, X.
    Zhang, H. -Z.
    Lin, H. -L.
    Feng, Y.
    Shao, J. -Y.
    Huang, W. -L.
    Kung, H. -F.
    Zeng, M. -S.
    ANNALS OF ONCOLOGY, 2010, 21 (12) : 2361 - 2369
  • [23] Low spinophilin expression is associated with poor prognosis and cellular growth in human breast cancer
    Schwarzenbacher, D.
    Stiegelbauer, V.
    Deutsch, A.
    Ress, A. L.
    Aigelsreiter, A.
    Schauer, S.
    Gerger, A.
    Hoefler, G.
    Rinner, B.
    Pichler, M.
    ANNALS OF ONCOLOGY, 2015, 26
  • [24] Adipophilin expression as an independent marker for poor prognosis of patients with triple-negative breast cancer.
    Yoshikawa, Katsuhiro
    Ishida, Mitsuaki
    Yanai, Hirotsugu
    Tsuta, Koji
    Sekimoto, Mitsugu
    Sugie, Tomoharu
    JOURNAL OF CLINICAL ONCOLOGY, 2020, 38 (15)
  • [25] miR-21 Expression in Pregnancy-Associated Breast Cancer: A Possible Marker of Poor Prognosis
    Walter, Beatriz A.
    Gomez-Macias, Gabriela
    Valera, Vladimir A.
    Sobel, Mark
    Merino, Maria J.
    JOURNAL OF CANCER, 2011, 2 : 67 - 75
  • [26] High expression of FOXR2 in breast cancer correlates with poor prognosis
    Song, Haiping
    He, Wenshan
    Huang, Xiaoqing
    Zhang, Huiqiong
    Huang, Tao
    TUMOR BIOLOGY, 2016, 37 (05) : 5991 - 5997
  • [27] Increased MTHFD2 expression is associated with poor prognosis in breast cancer
    Liu, Feng
    Liu, Yang
    He, Chuan
    Tao, Li
    He, Xiaoguang
    Song, Hongtao
    Zhang, Guoqiang
    TUMOR BIOLOGY, 2014, 35 (09) : 8685 - 8690
  • [28] Increased Expression of DNA2 Was Linked to Poor Prognosis in Breast Cancer
    Han, Yingyan
    Zhang, Zeyu
    Wang, Zhi
    Sun, Shujuan
    DISEASE MARKERS, 2021, 2021
  • [29] Cyclo-oxygenase 2 expression correlates with poor prognosis in breast cancer
    Nature Clinical Practice Oncology, 2007, 4 (6): : 332 - 332
  • [30] Low expression of bestrophin-2 is associated with poor prognosis in colon cancer
    Wang, Li
    Zhu, Huawei
    Sun, Weiliang
    Liang, Li
    Li, Hui
    Han, Chenglong
    Huang, Wenfeng
    Zhao, Bi
    Peng, Peng
    Qin, Mengbin
    Shi, Ling
    Mo, Yueqing
    Huang, Jiean
    GENE, 2022, 813
12345